<?xml version="1.0" encoding="UTF-8"?>
<p>The B16F1 tumor cell line: (ATCC
 <sup>®</sup> CRL-6322™, Manassas, VA, USA), with epithelial morphology and adherent growth, from C57BL/6J mouse skin, was cultivated at 37 °C with 5% CO
 <sub>2</sub> and 98% humidity (Precision Scientific NAPCO 5410-120 Water Jacketed CO
 <sub>2</sub> Incubator, Buffalo, NY, USA) in DMEM advance (Dulbecco’s modification of Eagles medium) (Gibco, Thermo Fisher Scientific, Waltham, MS, USA) supplemented with 10% (
 <italic>v</italic>/
 <italic>v</italic>) fetal bovine serum (SFB) (Gibco), pH 7.2–7.4 condition, penicillin (100 U/mL), and streptomycin (100 µg/mL). The cells, at 70% confluence, treated with trypsin-EDTA (Sigma-Aldrich, St. Louis, MO, USA) 0.25% (
 <italic>m</italic>/
 <italic>v</italic>), resuspended and counted in automatic Tali™ Image-based Cytometer (Thermo Fisher Scientific) following the manufacturer’s specifications and their viability evaluated in Newbauer’s Chamber in dilution 1:1 with Trypan Blue (Sigma-Aldrich).
</p>
